No Nonsense: David Liu Lauds Progress in Disease-Agnostic Gene Editing at ESGCT

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 30 Oct, 15:38 UTC

Liu ensured that his return visit to ESGCT (having spoken at the congress in Barcelona in 2019) would be one of the highlights of the conference. The “meta lesson” of the past few years in therapeutic genome editing is that different scientific approaches and applications can synergize with…

science

Sources

• T2No Nonsense: David Liu Lauds Progress in Disease-Agnostic Gene Editing at ESGCTFierce Biotech / Fierce Healthcare / MedCity / GEN30 Oct, 15:38